StockData
Soligenix, Inc. logo

Soligenix, Inc. (SNGX) stock

SNGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$0.24−0.01 (-5.06%)

Close on Nov 19, 2026Market cap $5.22MP/E –Yield –

Soligenix net income

Net income is the profit left for shareholders after every expense, interest and tax.

Soligenix's net income for the twelve months ending Jun 30, 2026 was -$10.24M. For fiscal 2025 it was -$11.08M. The highest annual figure on record is -$2.38M in fiscal 2011.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$11.08M–
FY2024Dec 31, 2024-$8.27M–
FY2023Dec 31, 2023-$6.14M–
FY2022Dec 31, 2022-$13.80M–
FY2021Dec 31, 2021-$12.55M–
FY2020Dec 31, 2020-$17.69M–
FY2019Dec 31, 2019-$9.36M–
FY2018Dec 31, 2018-$8.90M–
FY2017Dec 31, 2017-$7.15M–
FY2016Dec 31, 2016-$3.25M–
FY2015Dec 31, 2015-$7.83M–
FY2014Dec 31, 2014-$6.71M–
FY2013Dec 31, 2013-$10.06M–
FY2012Dec 31, 2012-$4.16M–
FY2011Dec 31, 2011-$2.38M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.99M–
Q1 FY2026Mar 31, 2026-$2.82M–
Q4 FY2025Dec 31, 2025-$2.90M–
Q3 FY2025Sep 30, 2025-$2.53M–
Q2 FY2025Jun 30, 2025-$2.70M–
Q1 FY2025Mar 31, 2025-$2.95M–
Q4 FY2024Dec 31, 2024-$2.99M–
Q3 FY2024Sep 30, 2024-$1.72M–
Q2 FY2024Jun 30, 2024-$1.64M–
Q1 FY2024Mar 31, 2024-$1.92M–
Q4 FY2023Dec 31, 2023-$1.82M–
Q3 FY2023Sep 30, 2023-$1.66M–
Q2 FY2023Jun 30, 2023-$1.61M–
Q1 FY2023Mar 31, 2023-$1.05M–
Q4 FY2022Dec 31, 2022-$3.75M–
Q3 FY2022Sep 30, 2022-$3.31M–
Q2 FY2022Jun 30, 2022-$2.39M–
Q1 FY2022Mar 31, 2022-$4.35M–
Q4 FY2021Dec 31, 2021-$4.70M–
Q3 FY2021Sep 30, 2021-$3.59M–
Q2 FY2021Jun 30, 2021-$1.90M–
Q1 FY2021Mar 31, 2021-$2.36M–
Q4 FY2020Dec 31, 2020-$5.54M–
Q3 FY2020Sep 30, 2020-$1.79M–
Q2 FY2020Jun 30, 2020-$2.78M–
Q1 FY2020Mar 31, 2020-$7.58M–
Q1 FY2019Mar 31, 2019-$1.64M–
Q4 FY2018Dec 31, 2018-$3.10M–
Q3 FY2018Sep 30, 2018-$1.86M–
Q2 FY2018Jun 30, 2018-$1.56M–
Q1 FY2018Mar 31, 2018-$2.38M–
Q4 FY2017Dec 31, 2017-$2.14M–
Q3 FY2017Sep 30, 2017-$963.09K–
Q2 FY2017Jun 30, 2017-$2.31M–
Q1 FY2017Mar 31, 2017-$1.73M–
Q4 FY2016Dec 31, 2016-$329.96K–
Q3 FY2016Sep 30, 2016-$1.67M–
Q2 FY2016Jun 30, 2016-$92.78K–
Q1 FY2016Mar 31, 2016-$1.15M–

More Soligenix figures

See a number that looks wrong?